Condition

Huntington Disease

ClinicalTrials.gov condition label

Clinical trials31
Recruiting4
Common interventions25
Lead sponsors shown15

Clinical trials

31 shown
Development of Non-Invasive Prenatal Diagnosis for Single Gene DisordersNCT06147414 · 2024-10-23
RECRUITING
Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic PathologyNCT07136844 · 2024-03-29
RECRUITING
NYSCF Scientific Discovery BiobankNCT06203106 · 2022-11-10
RECRUITING
Retinal Imaging in Neurodegenerative DiseaseNCT03233646 · 2017-07-20
RECRUITING
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)NCT07213648 · 2025-11-20
ACTIVE_NOT_RECRUITING
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare DiseasesNCT06539169 · 2024-06-10
UNKNOWN
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their CaregiversNCT05596760 · 2023-09-11
ACTIVE_NOT_RECRUITING
Striatum and Hippocampus on Different Time ScalesNCT05943054 · 2023-01-06
UNKNOWN
Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register StudyNCT06209515 · 2022-01-01
ACTIVE_NOT_RECRUITING
Measurement and Modification of Threat Interpretation Bias in Neurodegenerative Movement Disorders (Aims 2 & 3)NCT05126862 · 2021-12-10
COMPLETED
Efficacy of Cognitive Rehabilitation Using Virtual Reality and Computer-based Cognitive Stimulation on Cognitive Impairment Associated to Movement DisordersNCT05769972 · 2021-10-13
COMPLETED
Complex Eye Movements in Parkinson's Disease and Related Movement DisordersNCT04925622 · 2021-01-04
COMPLETED
Assessing the Symptomatic Benefit of Acoustic Slow Wave Enhancement in Parkinson DiseaseNCT04589182 · 2020-10-20
UNKNOWN
Using Wearable and Mobile Data to Diagnose and Monitor Movement DisordersNCT04231487 · 2019-06-27
UNKNOWN
Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific ProductsNCT03886753 · 2019-05-15
TERMINATED
Group Drum-Based Music Therapy Intervention for Parkinson's Disease/Huntington's DiseaseNCT05157074 · 2019-01-09
COMPLETED
Genetic Risk: Whether, When, and How to Tell AdolescentsNCT03421327 · 2017-09-01
COMPLETED
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological PathologiesNCT03052712 · 2016-09-09
TERMINATED
Measuring Cortisol Levels in Persons With Parkinson's (PD)NCT02727270 · 2016-06-01
COMPLETED
Gait Analysis in Neurological DiseaseNCT02994719 · 2016-03-01
ACTIVE_NOT_RECRUITING
Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI)NCT02819700 · 2013-01-29
COMPLETED
Biological Sample Collection for Research and BiobankingNCT04270604 · 2012-02-06
TERMINATED
Study of Motor Slowing in Parkinson's Disease by a Computerized Mental Chronometry ParadigmNCT02814201 · 2011-07-01
COMPLETED
A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)NCT00988624 · 2009-10-01
COMPLETED
Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.NCT00970229 · 2009-07-01
COMPLETED
Assessment of Social-emotional Functioning in Neurological DiseasesNCT01339130 · 2009-06-01
COMPLETED
A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric ConditionsNCT00870974 · 2009-03-01
COMPLETED
Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy SubjectsNCT00831506 · 2009-02-01
COMPLETED
A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of DextromethorphanNCT00788047 · 2008-11-01
COMPLETED
Research of Biomarkers in Parkinson DiseaseNCT00465790 · 2007-10-01
COMPLETED
Memory Disorders RegistryNCT00654563 · 2007-08-01
COMPLETED

Common interventions

Biological sample collectionOTHER2[123I]MNI-420DRUG1[18F]FPEBDRUG19-Hole Peg Test (9-HPT)DIAGNOSTIC_TEST1Anti-Parkinson medicationDRUG1Blood sampleBIOLOGICAL1Complex eye movement examDIAGNOSTIC_TEST1Computer-based cognitive rehabilitation (Huntington's disease)DEVICE1Computer-based cognitive rehabilitation (Parkinson's disease)DEVICE1Computerized tests and Electrophysiological measurementsBEHAVIORAL1Deep Brain StimulationDEVICE1DextromethorphanDRUG1digoxinDRUG1dimebonDRUG1Dimebon + DextromethorphanDRUG1Dimebon IR TabletDRUG1Dimebon MR1DRUG1Dimebon MR2DRUG1Dimebon MR3DRUG1Dimebon MR4DRUG1Dynamometric measurements of muscle strengthDIAGNOSTIC_TEST1Group Drumming Music TherapyBEHAVIORAL1Immersive Virtual Reality (Parkinson's disease)DEVICE1Jumpstart GuideBEHAVIORAL1MHSL- SleepBandDEVICE1

Leading sponsors

Centre Hospitalier Universitaire, Amiens4Pfizer3Assistance Publique - Hôpitaux de Paris2Institute for Neurodegenerative Disorders2Johns Hopkins University2New York Stem Cell Foundation Research Institute2University of Virginia2Beth Israel Deaconess Medical Center1Cedars-Sinai Medical Center1Centre Hospitalier Universitaire de Liege1Children's Hospital of Philadelphia1Christian Baumann1Duke University1Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1Institut National de la Santé Et de la Recherche Médicale, France1

Trial status mix

COMPLETED16
ACTIVE_NOT_RECRUITING4
RECRUITING4
UNKNOWN4
TERMINATED3

Phase mix

NA10
PHASE15

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.